- Home
- NEGG vs OCGN Comparison
NEGG vs OCGN Comparison
Compare NEGG & OCGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- OCGN
- Stock Information
- Founded
- NEGG 2001
- OCGN 2013
- Country
- NEGG United States
- OCGN United States
- Employees
- NEGG N/A
- OCGN N/A
- Industry
- NEGG Other Specialty Stores
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NEGG Consumer Discretionary
- OCGN Health Care
- Exchange
- NEGG Nasdaq
- OCGN Nasdaq
- Market Cap
- NEGG 293.6M
- OCGN 246.8M
- IPO Year
- NEGG 2010
- OCGN N/A
- Fundamental
- Price
- NEGG $0.49
- OCGN $0.80
- Analyst Decision
- NEGG
- OCGN Strong Buy
- Analyst Count
- NEGG 0
- OCGN 3
- Target Price
- NEGG N/A
- OCGN $5.67
- AVG Volume (30 Days)
- NEGG 719.2K
- OCGN 3.8M
- Earning Date
- NEGG 12-31-2024
- OCGN 11-08-2024
- Dividend Yield
- NEGG N/A
- OCGN N/A
- EPS Growth
- NEGG N/A
- OCGN N/A
- EPS
- NEGG N/A
- OCGN N/A
- Revenue
- NEGG $1,391,833,000.00
- OCGN $4,700,000.00
- Revenue This Year
- NEGG $6.01
- OCGN N/A
- Revenue Next Year
- NEGG N/A
- OCGN N/A
- P/E Ratio
- NEGG N/A
- OCGN N/A
- Revenue Growth
- NEGG N/A
- OCGN N/A
- 52 Week Low
- NEGG $0.44
- OCGN $0.37
- 52 Week High
- NEGG $1.45
- OCGN $2.11
- Technical
- Relative Strength Index (RSI)
- NEGG 32.35
- OCGN 36.72
- Support Level
- NEGG $0.43
- OCGN $0.81
- Resistance Level
- NEGG $0.66
- OCGN $0.89
- Average True Range (ATR)
- NEGG 0.04
- OCGN 0.05
- MACD
- NEGG -0.01
- OCGN -0.01
- Stochastic Oscillator
- NEGG 22.96
- OCGN 4.35
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally.
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").